The two sessions (NPC & CPPCC) this year have received much attention from China and outside China, wherein, the most-watched theme is “reform”. Regarding pharmaceuticals, the event that attracts the highest attention is CFDA reform, followed by policy moves of the TCM issue and bio-medicine, etc. that China has been strongly supporting in recent years.
This year could see a transformation in the Japanese pharma market, according to a new report, with strong growth stemming from increased use of generics, biosimilars and stronger links with the global industry.
The International Pharmaceutical Networking Exhibition (CPhI Worldwide 2017), will be held at Ludwig-Erhard-Anlage 1 in Messe Frankfurt, Germany from the 24th to the 26th of October 2017. As the leading global pharmaceutical & medical device B2B online platform, Ddu is going to attend the exhibition, showcasing the new Chinese cross-border medical trade method to Germany and the whole world.
The 2017 CPhI Korea was grandly held at the Convention Center Grand Ball Room, Seoul, South Korea from August 22nd to August 24th. Ddu, the leading global pharmaceutical and medical device B2B online platform, attended the exhibition where their management concept and service method proved why they are a leader in their field.
CPhI China 2017 was held at the Shanghai New International Expo Center from June 20 to 22. As the leading global pharmaceuticals and medical devices industry platform, Ddu presented a wide range of services which connect the traditional medical industry with the Internet including one-stop service solutions, buying offer sharing of global exhibitions, credit verification and so forth.
CPhI China 2017 will be held from 20th June to 22nd June 2017 at the Shanghai New International Expo Center (SNIEC) in Shanghai, China. Ddu, the leading global pharmaceuticals and medical devices B2B platform , will attend the exhibition with products from high-priority members and launch synchronization services of buy offers and agency service.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.